MedPath

The impact of milk protein glycation on muscle protein synthesis after resistance training in healthy young me

Completed
Conditions
Spieropbouw na inspanning
building muscle protein
Muscle protein synthesis
Registration Number
NL-OMON49398
Lead Sponsor
niversiteit Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
53
Inclusion Criteria

- Males
- Aged between 18-35 years
- Healthy, recreationally active (participating in recreational sports
activities * 1 and * 6 h per week, with a maximum of 2 h resistance-type
exercise)
- 18.5 * BMI * 30 kg/m2
- No physical limitations (i.e. able to perform all activities associated with
daily living in an independent manner).

Exclusion Criteria

- Smoking
- Lactose intolerant or allergies to milk proteins
- Regular consumption of protein supplements (e.g. protein powders)
- Musculoskeletal disorders
- Metabolic disorders
- Use of any medications known to affect protein metabolism (i.e.
corticosteroids, non-steroidal anti-inflammatories, or prescribed acne
medications).
- Chronic use of gastric acid suppressing medication or anti-coagulants
- Recent (<9 months) participation in amino acid tracer
(L-[ring-13C6]-phenylalanine and L-[3,5-2H2]-tyrosine) studies
- Unstable weight over the last three months
- Diagnosed GI tract disorders or diseases
- Blood donation in the past 2 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary endpoint will be mixed muscle protein synthesis rates over the full<br /><br>assessment period (6h h), as determined using contemporary stable isotope<br /><br>tracer methodology combined with multiple muscle and blood samples. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>To compare the impact of low versus high protein glycation on peak plasma<br /><br>lysine concentration, overall plasma amino acid responses, plasma insulin-, and<br /><br>glucose responses. </p><br>
© Copyright 2025. All Rights Reserved by MedPath